Avadel Pharmaceuticals
AVDL
#6138
Rank
A$1.08 B
Marketcap
$11.25
Share price
-5.56%
Change (1 day)
-55.34%
Change (1 year)

Earnings for Avadel Pharmaceuticals (AVDL)

Earnings in 2024 (TTM): -A$74.88 Million

According to Avadel Pharmaceuticals 's latest financial reports the company's current earnings are A$0.16 Billion. , an increase over its 2023 earnings that were of -A$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Avadel Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 -A$81.18 Million-69.47%
2023 -A$0.27 Billion44.27%
2022 -A$0.19 Billion19.64%
2021 -A$0.16 Billion1732.84%
2020 -A$8.41 Million-86.83%
2019 -A$63.82 Million-65.92%
2018 -A$0.19 Billion-222.16%
2017 A$0.15 B-1053.49%
2016 -A$16.08 Million-112.59%
2015 A$0.12 B-185.94%
2014 -A$0.15 Billion66.04%
2013 -A$89.48 Million582.16%
2012 -A$13.12 Million-7.6%
2011 -A$14.2 Million-2.1%
2010 -A$14.5 Million32.52%
2009 -A$10.95 Million-64.36%
2008 -A$30.71 Million-52.93%
2007 -A$65.22 Million5.66%
2006 -A$61.73 Million17.86%
2005 -A$52.38 Million-375.09%
2004 A$19.03 M-406.44%
2003 -A$6.22 Million-145.2%
2002 A$13.74 M-363.36%
2001 -A$5.22 Million-80.62%
2000 -A$26.94 Million132.68%
1999 -A$11.58 Million-50.34%
1998 -A$23.31 Million54.85%
1997 -A$15.06 Million-28.35%
1996 -A$21.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$30.04 Million-63.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$17.15 Million-78.89%๐Ÿ‡บ๐Ÿ‡ธ USA